Objectives <p>Thoracic aortic aneurysm and dissection (TAAD) is a life-threatening condition for which early risk stratification and preventive strategies present critical challenges. Although genetic contributions are well established in high-risk populations, the clinical relevance of rare variants in the general population remains poorly understood. We aimed to explore the association between low-frequency homozygous minor allele genotypes in TAAD-related genes and TAAD-related mortality using a Japanese community-based cohort.</p> Methods <p>We selected 14 single-nucleotide polymorphisms from genes with definitive or strong clinical validity for TAAD, based on the criterion that the frequency of individuals homozygous for the minor allele was less than 5%. Participants with any low-frequency homozygous minor allele genotypes were classified as carriers, while those without such genotypes were classified as non-carriers. The primary outcome was TAAD-related mortality, and we examined whether carrier status was associated with the risk of TAAD-related death.</p> Results <p>Among 24,478 participants, we analyzed 5,722 individuals (1,499 carriers and 4,223 non-carriers) who had genome-wide genotyping data. TAAD-related deaths were observed in 12 individuals (8 carriers and 4 non-carriers). Carriers exhibited lower survival rates compared to non-carriers. Univariate Cox model analysis showed carrier status was associated with increased TAAD-related mortality. These variants had not been previously classified as pathogenic.</p> Conclusion <p>Low-frequency homozygous minor allele genotypes in established TAAD-related genes were associated with TAAD-related mortality in a general Japanese population. These findings should be interpreted as hypothesis-generating and are limited to mortality as the endpoint, providing population-based epidemiological evidence on the potential clinical relevance of currently unclassified variants.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Potential association of genetic variants with thoracic aortic aneurysm and dissection: Evidence from a Japanese community-based cohort

  • Kentaro Akabane,
  • Ken Nakamura,
  • Hidenori Sato,
  • Tsuneo Konta,
  • Shusuke Arai,
  • Yasushi Imai,
  • Tetsuro Uchida

摘要

Objectives

Thoracic aortic aneurysm and dissection (TAAD) is a life-threatening condition for which early risk stratification and preventive strategies present critical challenges. Although genetic contributions are well established in high-risk populations, the clinical relevance of rare variants in the general population remains poorly understood. We aimed to explore the association between low-frequency homozygous minor allele genotypes in TAAD-related genes and TAAD-related mortality using a Japanese community-based cohort.

Methods

We selected 14 single-nucleotide polymorphisms from genes with definitive or strong clinical validity for TAAD, based on the criterion that the frequency of individuals homozygous for the minor allele was less than 5%. Participants with any low-frequency homozygous minor allele genotypes were classified as carriers, while those without such genotypes were classified as non-carriers. The primary outcome was TAAD-related mortality, and we examined whether carrier status was associated with the risk of TAAD-related death.

Results

Among 24,478 participants, we analyzed 5,722 individuals (1,499 carriers and 4,223 non-carriers) who had genome-wide genotyping data. TAAD-related deaths were observed in 12 individuals (8 carriers and 4 non-carriers). Carriers exhibited lower survival rates compared to non-carriers. Univariate Cox model analysis showed carrier status was associated with increased TAAD-related mortality. These variants had not been previously classified as pathogenic.

Conclusion

Low-frequency homozygous minor allele genotypes in established TAAD-related genes were associated with TAAD-related mortality in a general Japanese population. These findings should be interpreted as hypothesis-generating and are limited to mortality as the endpoint, providing population-based epidemiological evidence on the potential clinical relevance of currently unclassified variants.